Seres Therapeutics, Inc. Gains 39.43%
Fri, Nov 03, 2023 at 07:12 PM
Seres Therapeutics, Inc. (MCRB:NASDAQ) soared at $1.3, a gain of 39.4%. On Fri, Nov 03, 2023, MCRB:NASDAQ hit a New 2-Week Intraday High of $1.55. The stock appeared on our News Catalysts scanner on Thu, Nov 02, 2023 at 11:54 AM in the 'MISCELLANEOUS' category. From Fri, Oct 20, 2023, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Wed, Jun 14, 2023 at $6.26 with a volume of 2M+.
About Seres Therapeutics, Inc. (MCRB:NASDAQ)
Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 999900%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 99%
- SRAX, Inc. (SRAX:NASDAQ), 87.5%
- Benson Hill Inc. (BHIL:NYSE), 58%
- Kaixin Auto Holdings (KXIN:NASDAQ), 49.57%
- Tenon Medical Inc. (TNON:NASDAQ), 47.69%
- Werewolf Therapeutics Inc. (HOWL:NASDAQ), 47.44%
- Cooper-Standard Holdings Inc. (CPS:NYSE), 43.83%
- Seres Therapeutics, Inc. (MCRB:NASDAQ), 39.43%
- Udemy Inc. (UDMY:NASDAQ), 38.03%